Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

NOT YET RECRUITING

NCT06798675

PHASE2

Phase 2a Study for PK/PD of nC-001

Sponsor: nephCentric

View on ClinicalTrials.gov

Summary

CHRONIC EUVOLEMIC HYPONATREMIA

Official title: A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, DOSE-RANGING CLINICAL TRIAL TO EVALUATE THE PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF nC-001 IN PATIENTS WITH CHRONIC EUVOLEMIC HYPONATREMIA

Key Details

Gender

All

Age Range

18 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

Start Date

2025-08

Completion Date

2026-06

Last Updated

2025-05-29

Healthy Volunteers

Conditions

CHRONIC HYPONATREMIA

Interventions

DRUG

nC-001

solid dosage form single dose